Keros Therapeutics, Inc. · NASDAQ:KROS

Keros Therapeutics, Inc. shareholders

As of Sep 30, 2026, 130 institutions reported holding Keros Therapeutics, Inc., 95.0% of its shares. Largest: BlackRock, Vanguard and Nantahala Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Keros Therapeutics, Inc.ChangeFiled
BlackRock3.5M17.8%+707KNov 13, 2026
Vanguard1.61M8.2%−14,767Nov 13, 2026
Nantahala Capital Management, LLC1.49M7.6%−1.33MNov 13, 2026
AQR Capital Management LLC804K4.1%−164KNov 16, 2026
Orbimed Advisors LLC759K3.9%no changeNov 16, 2026
Mackenzie743K3.8%+114KNov 2, 2026
Federated Hermes, Inc.707K3.6%+6,627Nov 12, 2026
Madison Avenue Partners, LP627K3.2%no changeNov 16, 2026
Two Sigma548K2.8%+301KNov 16, 2026
State Street542K2.8%+405Nov 12, 2026

Keros Therapeutics, Inc. insider trades